Pathstone Family Office LLC Trims Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Pathstone Family Office LLC has recently announced that it has trimmed its stock position in Pacific Biosciences of California, Inc. (NASDAQ: PACB) by selling a portion of its shares. The exact amount of shares sold and the reasons for the sale were not disclosed in the announcement.

Pacific Biosciences is a biotechnology company that develops and manufactures sequencing instruments, reagents, and software for life sciences research and clinical applications. The company's flagship product is the PacBio Sequel II, which is used for whole-genome sequencing and other applications in fields such as genomics, microbiology, and oncology.

Pathstone Family Office LLC is a private investment firm that provides wealth management services to high net worth individuals and families. The company has a diversified portfolio of investments across various asset classes, including equities, fixed income, real estate, and alternative investments.

It's important to note that this information is based on publicly available sources and should not be considered as financial advice. It's always recommended to consult with a financial advisor before making any investment decisions.